{"id":538469,"date":"2026-06-30T03:21:31","date_gmt":"2026-06-30T03:21:31","guid":{"rendered":"https:\/\/www.newjerseyheadlines.com\/news\/story\/538469\/transdermal-drug-delivery-devices-market-expanding-revenue-landscape-to-2032-delveinsight.html"},"modified":"2026-06-30T03:21:31","modified_gmt":"2026-06-30T03:21:31","slug":"transdermal-drug-delivery-devices-market-expanding-revenue-landscape-to-2032-delveinsight","status":"publish","type":"post","link":"http:\/\/www.northcarolinaheadlines.com\/news\/story\/538469\/transdermal-drug-delivery-devices-market-expanding-revenue-landscape-to-2032-delveinsight.html","title":{"rendered":"Transdermal Drug Delivery Devices Market: Expanding Revenue Landscape to 2032 \u2013 DelveInsight"},"content":{"rendered":"<div style=\"font-style:italic;padding:8px 0px\">DelveInsight&#8217;s &#8220;Transdermal Drug Delivery Devices Market Insights and Forecast-2032&#8221; report offers an in-depth understanding of the Transdermal Drug Delivery Devices, historical and forecasted market size, as well as the Transdermal Drug Delivery Devices market trends in North America, Europe, Asia-Pacific, and the Rest of the World.<\/div>\n<p style=\"text-align: justify\">Some of the Key Facts of the Transdermal Drug Delivery Devices Market Report<\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p class=\"caps\">The Transdermal Drug Delivery Devices market size is anticipated to grow with a significant CAGR of 6.91% during the study period (2022-2032).<\/p>\n<\/li>\n<li>\n<p>The transdermal drug delivery devices market was valued at USD 71,566.27 million in 2024, and projected to reach USD 121,798.76 million by 2032, growing at a CAGR of 6.91% during the forecast period from 2025 to 2032.<\/p>\n<\/li>\n<li>\n<p>In July 2024, Kindeva Drug Delivery&#8217;s Woodbury, MN facility was FDA-inspected and classified, enabling the facility to support clients with integrated and stand-alone analytical services for pharmaceutical, biopharmaceutical, and medical device sectors.<\/p>\n<\/li>\n<li>\n<p>In March 2024, PassPort Technologies, Inc., a San Diego-based clinical-stage company, reported positive interim results from its Phase 1 trial of Zolmitriptan PassPort&reg;, using a proprietary transdermal microporation system for acute migraine treatment.<\/p>\n<\/li>\n<li>\n<p>In February 2024, LTS LOHMANN Therapie-Systeme AG announced the launch of the UDENYCA&reg; on-body injector (OBI) through its Sorrel&trade; platform, aimed at reducing infection risks post-chemotherapy. The device was approved by the FDA in December 2023.<\/p>\n<\/li>\n<li>\n<p>In January 2024, Starton Therapeutics announced the launch of STARSILON, a novel proprietary transdermal patch delivery platform.<\/p>\n<\/li>\n<li>\n<p>The transdermal drug delivery devices market is currently led by major pharmaceutical and device players, including Novartis, Viatris Inc., and Hisamitsu Pharmaceutical, which provide approved products such as TRANSDERM-V and the Mylan-rivastigmine Patch 10. The market is expected to witness substantial growth in the coming years.<\/p>\n<\/li>\n<li>\n<p>According to recent data from the Centers for Disease Control and Prevention (2024), approximately 4.9% of adults were diagnosed with coronary heart disease in 2022.<\/p>\n<\/li>\n<li>\n<p>According to recent data provided by the British Heart Foundation (2024), globally, approximately 620 million people, or about 1 in 13 individuals, live with heart and circulatory diseases.<\/p>\n<\/li>\n<li>\n<p>According to the World Health Organization (2024), epilepsy affects approximately 50 million people worldwide, making it one of the most prevalent neurological disorders globally.<\/p>\n<\/li>\n<li>\n<p>The Transdermal Drug Delivery Devices market by type analyzed that, the drug-in-adhesive patches category dominated the market with a share of 55.44% in 2024, owing to its convenience, controlled drug release, and patient-friendly, non-invasive application.<\/p>\n<\/li>\n<li>\n<p>North America Transdermal Drug Delivery Devices market is estimated to hold the largest share of 45.39% in the global market in 2024, growing at a CAGR of 5.91% during the forecast period from 2025 to 2032.<\/p>\n<\/li>\n<li>\n<p>The Transdermal Drug Delivery Devices market is expected to surge due to the growing prevalence of chronic conditions and the increasing adoption of third-generation transdermal drug delivery devices during the forecast period. Furthermore, technological advancements such as microneedles, nanocarriers, and smart connected patches will significantly revolutionize the Transdermal Drug Delivery Devices market dynamics.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\">Get a Free Sample for the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transdermal-drug-delivery-devices-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=mpr\">Transdermal Drug Delivery Devices Market Report<\/a><\/p>\n<p style=\"text-align: justify\">Key Transdermal Drug Delivery Devices Companies<\/p>\n<p style=\"text-align: justify\">Novartis, Viatris Inc., UCB SA, Hisamitsu Pharmaceutical, Boehringer Ingelheim, Johnson &amp; Johnson Services Inc., Purdue Pharma, Bayer AG, Haleon Group of Companies, Ingenus Pharmaceuticals, Luye Pharma Group, Cumberland Pharmaceuticals Inc., Sanofi, Sparsha Pharma International Pvt Ltd., Cipla, and others<\/p>\n<p style=\"text-align: justify\">Key Transdermal Drug Delivery Devices Types<\/p>\n<p style=\"text-align: justify\">Drug-in-adhesive Patches, Matrix Patches, Reservoir Membrane Patches, and Microneedle Patches<\/p>\n<p style=\"text-align: justify\">Transdermal Drug Delivery Devices Overview<\/p>\n<p style=\"text-align: justify\">Transdermal drug delivery devices are systems designed to deliver medications through the skin and into the bloodstream in a controlled and consistent manner. They include drug-in-adhesive patches, matrix patches, reservoir membrane patches, and microneedle patches, each engineered to bypass the gastrointestinal tract and first-pass metabolism. These devices are used across a wide range of therapeutic areas, including pain management, central nervous system disorders, hormonal applications, and cardiovascular disorders. While there are challenges such as skin irritation and inconsistent systemic absorption for some formulations, ongoing innovation in microneedle platforms, skin-penetration enhancers, and smart sensor integration continues to expand the range of drugs that can be delivered transdermally.<\/p>\n<p style=\"text-align: justify\">To Know in detail about the Transdermal Drug Delivery Devices market outlook, device uptake, and competitive landscape, Click here; Transdermal Drug Delivery Devices Market Forecast<\/p>\n<p style=\"text-align: justify\">Transdermal Drug Delivery Devices Market Dynamics<\/p>\n<p style=\"text-align: justify\">The market dynamics section provides insights into the historical, current, and forecasted market trends across North America, Europe, Asia-Pacific, and the Rest of the World from 2022 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies, regulatory developments, and industry activity. The market dynamics section also provides a detailed analysis of device adoption, technological innovation, and regional growth trends.<\/p>\n<p style=\"text-align: justify\">Transdermal Drug Delivery Devices Market Segmentation<\/p>\n<p style=\"text-align: justify\">The Transdermal Drug Delivery Devices market report proffers market analysis for the study period 2022&ndash;2032 segmented into:<\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p>Market by Type (Drug-in-adhesive Patches, Matrix Patches, Reservoir Membrane Patches, and Microneedle Patches)<\/p>\n<\/li>\n<li>\n<p>Market by Application (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Disorders, and Others)<\/p>\n<\/li>\n<li>\n<p>Market by End-User (Hospitals, Ambulatory Surgical Centers, and Others)<\/p>\n<\/li>\n<li>\n<p>Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\">Download the report to understand which factors are driving Transdermal Drug Delivery Devices market trends @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transdermal-drug-delivery-devices-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=mpr\">Transdermal Drug Delivery Devices Market Trends<\/a><\/p>\n<p style=\"text-align: justify\">Transdermal Drug Delivery Devices Uptake and Pipeline Development Activities<\/p>\n<p style=\"text-align: justify\">The device uptake section focuses on the rate of adoption of the potential devices recently launched in the Transdermal Drug Delivery Devices market or expected to get launched during the study period. The analysis covers Transdermal Drug Delivery Devices market uptake by type, adoption by application, and sales of each device category.<\/p>\n<p style=\"text-align: justify\">Moreover, the competitive assessment section helps understand the devices with the most rapid uptake and the reasons behind the maximal use of these devices. Additionally, it compares devices based on market share.<\/p>\n<p style=\"text-align: justify\">The report also covers the Transdermal Drug Delivery Devices Pipeline Development Activities. It provides valuable insights about different device candidates in various stages and the key companies involved in developing targeted delivery platforms. It also analyzes recent developments such as collaborations, acquisitions, mergers, regulatory approvals, and other information for emerging technologies.<\/p>\n<p style=\"text-align: justify\">Discover more about devices set to grab major Transdermal Drug Delivery Devices market share @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transdermal-drug-delivery-devices-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=mpr\"> Transdermal Drug Delivery Devices Treatment Market<\/a><\/p>\n<p style=\"text-align: justify\">Transdermal Drug Delivery Devices Market Drivers<\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p>Rapid rise in chronic diseases: Conditions that need long-term, steady medication such as diabetes, cardiovascular disease, and pain management are increasing demand for convenient transdermal options.<\/p>\n<\/li>\n<li>\n<p>Technological advances: Innovations like microneedles, nanocarriers, skin-penetration enhancers, and novel adhesives have expanded the range of drugs that can be delivered through the skin.<\/p>\n<\/li>\n<li>\n<p>Patient preference for non-invasive, at-home care: Patches and wearables reduce injections and hospital visits, improving adherence and quality of life.<\/p>\n<\/li>\n<li>\n<p>Growth of &#8220;smart&#8221;\/connected patches: Integration of sensors and digital monitoring enables personalized dosing, adherence tracking, and remote care.<\/p>\n<\/li>\n<li>\n<p>Aging population: Larger geriatric cohorts who often prefer simpler, less invasive administration support market uptake.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\">Transdermal Drug Delivery Devices Market Barriers<\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p>Skin irritation and adverse reactions: Irritation at the application site, edema, and increased product recalls may hinder adoption and continued use of certain devices.<\/p>\n<\/li>\n<li>\n<p>Technical challenges in dosing consistency: Many patches struggle to deliver consistent doses or achieve meaningful systemic absorption, limiting their applicability for certain drug classes.<\/p>\n<\/li>\n<li>\n<p>Tariff and supply chain pressures: The imposition of import tariffs on medical devices and components has increased costs and disrupted supply chains, prompting strategic shifts in manufacturing and sourcing.<\/p>\n<\/li>\n<li>\n<p>High cost and reimbursement gaps: Long-term device costs and inconsistent insurance coverage limit accessibility, especially in cost-sensitive regions.<\/p>\n<\/li>\n<li>\n<p>Regulatory and safety concerns: Safety warnings, such as the FDA&#8217;s 2025 alert on heat-related overdose risks with scopolamine patches, can affect prescriber and patient confidence.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\">Scope of the Transdermal Drug Delivery Devices Market Report<\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p>Study Period: 2022&ndash;2032<\/p>\n<\/li>\n<li>\n<p>Coverage: North America, Europe, Asia-Pacific, and Rest of the World<\/p>\n<\/li>\n<li>\n<p>Key Transdermal Drug Delivery Devices Companies: Novartis, Viatris Inc., UCB SA, Hisamitsu Pharmaceutical, Boehringer Ingelheim, Johnson &amp; Johnson Services Inc., Purdue Pharma, Bayer AG, Haleon Group of Companies, Ingenus Pharmaceuticals, Luye Pharma Group, Cumberland Pharmaceuticals Inc., Sanofi, Sparsha Pharma International Pvt Ltd., Cipla, and others<\/p>\n<\/li>\n<li>\n<p>Key Transdermal Drug Delivery Devices Types: Drug-in-adhesive Patches, Matrix Patches, Reservoir Membrane Patches, and Microneedle Patches<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Assessment: Current marketed and emerging transdermal delivery technologies<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Market Dynamics: Market drivers and market barriers<\/p>\n<\/li>\n<li>\n<p>Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter&#8217;s five forces, BCG Matrix, Market entry strategies<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Unmet Needs: KOL&#8217;s views, Analyst&#8217;s views, Market Access and Reimbursement<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\">To know more about Transdermal Drug Delivery Devices companies working in the market, visit @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transdermal-drug-delivery-devices-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=mpr\">Transdermal Drug Delivery Devices Clinical Trials and Competitive Assessment<\/a><\/p>\n<p style=\"text-align: justify\">Table of Contents<\/p>\n<ol style=\"text-align: justify\">\n<li>\n<p>Transdermal Drug Delivery Devices Market Report Introduction<\/p>\n<\/li>\n<li>\n<p>Executive Summary for Transdermal Drug Delivery Devices<\/p>\n<\/li>\n<li>\n<p>SWOT analysis of Transdermal Drug Delivery Devices<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Market Share (%) Overview at a Glance<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Market Overview at a Glance<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Background and Overview<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Market and Adoption Trends<\/p>\n<\/li>\n<li>\n<p>Country-Specific Market Analysis of Transdermal Drug Delivery Devices<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Current Treatment and Medical Practices<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Unmet Needs<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Emerging Technologies<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Market Outlook<\/p>\n<\/li>\n<li>\n<p>Country-Wise Transdermal Drug Delivery Devices Market Analysis (2022&ndash;2032)<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Market Access and Reimbursement<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Market Drivers<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Market Barriers<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Appendix<\/p>\n<\/li>\n<li>\n<p>Transdermal Drug Delivery Devices Report Methodology<\/p>\n<\/li>\n<li>\n<p>DelveInsight Capabilities<\/p>\n<\/li>\n<li>\n<p>Disclaimer<\/p>\n<\/li>\n<li>\n<p>About DelveInsight<\/p>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify\">About DelveInsight<\/p>\n<p style=\"text-align: justify\">DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.<\/p>\n<p><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56421.html\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Mehul Malhotra<br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=transdermal-drug-delivery-devices-market-expanding-revenue-landscape-to-2032-delveinsight\">Send Email<\/a><br \/><strong>Phone:<\/strong> 09650213330<br \/><strong>Address:<\/strong>63, M3M 113 Market, Sector 113  <br \/><strong>City:<\/strong> Gurugram<br \/><strong>State:<\/strong> IN &#8211; Indiana<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a rel=\"nofollow noopener\" href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=transdermal-drug-delivery-devices-market-expanding-revenue-landscape-to-2032-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight&#8217;s &#8220;Transdermal Drug Delivery Devices Market Insights and Forecast-2032&#8221; report offers an in-depth understanding of the Transdermal Drug Delivery Devices, historical and forecasted market size, as well as the Transdermal<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/538469"}],"collection":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/comments?post=538469"}],"version-history":[{"count":0,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/538469\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/media?parent=538469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/categories?post=538469"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/tags?post=538469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}